ANGO Angiodynamics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ANGO

Price (delayed)

$12.365

Market cap

$520M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.78

Enterprise value

$486.03M

?
Relative Growth: Rel. Growth: 27
Relative Strength: Rel. Strength: 52
Relative Valuation: Rel. Valuation: 22
Relative Profitability: Rel. Profitability: 28

AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for ...

Highlights
Angiodynamics's EPS has increased by 11% from the previous quarter
ANGO's gross profit is up by 11% year-on-year and by 3.5% since the previous quarter
The quick ratio has increased by 11% YoY but it has decreased by 3.6% QoQ
ANGO's net income is up by 10% since the previous quarter but it is down by 2.6% year-on-year
Angiodynamics's equity has decreased by 8% YoY and by 4% from the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.angiodynamics.com
Peers: LMAT MMSI TFX ICUI

Key stats

What are the main financial stats of ANGO

ANGO stock price

How has the Angiodynamics stock price performed over time
Intraday
2.87%
1 week
10.01%
1 month
-20.28%
1 year
3.04%
YTD
-3.7%
QTD
-19.6%

Financial performance

How have Angiodynamics's revenue and profit performed over time
Revenue
$325.38M
Gross profit
$181.08M
Operating income
-$32.65M
Net income
-$32.94M
Gross margin
55.7%
Net margin
-10.1%
The company's net margin rose by 12% QoQ and by 6% YoY
ANGO's gross profit is up by 11% year-on-year and by 3.5% since the previous quarter
The company's operating margin rose by 11% QoQ and by 7% YoY
ANGO's net income is up by 10% since the previous quarter but it is down by 2.6% year-on-year

Price vs fundamentals

How does ANGO's price correlate with its fundamentals

Growth

What is Angiodynamics's growth rate over time

Valuation

What is Angiodynamics stock price valuation
P/E
N/A
P/B
3.12
P/S
1.6
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.49
Angiodynamics's EPS has increased by 11% from the previous quarter
The P/B is 59% more than the 5-year quarterly average of 1.9 but 2.3% less than the last 4 quarters average of 3.1
Angiodynamics's equity has decreased by 8% YoY and by 4% from the previous quarter
The P/S is 9% less than the last 4 quarters average of 1.7 and 3.1% less than the 5-year quarterly average of 1.6
The revenue has increased by 8% year-on-year

Efficiency

How efficient is Angiodynamics business performance
Angiodynamics's ROS has increased by 12% from the previous quarter and by 8% YoY
ANGO's ROA is down by 11% year-on-year but it is up by 8% since the previous quarter
The ROE is down by 10% year-on-year but it is up by 9% since the previous quarter
ANGO's ROIC is up by 9% QoQ

Dividends

What is ANGO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ANGO.

Financial health

How did Angiodynamics financials performed over time
The company's total liabilities fell by 19% QoQ and by 10% YoY
The quick ratio has increased by 11% YoY but it has decreased by 3.6% QoQ
The company's debt is 100% lower than its equity
Angiodynamics's equity has decreased by 8% YoY and by 4% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.